On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...